# | Title | Journal | Year | Citations |
---|
1 | Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review) | Oncology Letters | 2012 | 679 |
2 | Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients | Oncology Letters | 2012 | 483 |
3 | The emerging role of CXCL10 in cancer (Review) | Oncology Letters | 2011 | 322 |
4 | Depression in cancer patients: Pathogenesis, implications and treatment (Review) | Oncology Letters | 2015 | 276 |
5 | Cancer associated fibroblasts: An essential role in the tumor microenvironment | Oncology Letters | 2017 | 263 |
6 | Three‑dimensional cell culture: A powerful tool in tumor research and drug discovery (Review) | Oncology Letters | 2017 | 249 |
7 | PKM2 and cancer: The function of PKM2 beyond glycolysis | Oncology Letters | 2016 | 243 |
8 | Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention | Oncology Letters | 2013 | 222 |
9 | Epithelial-mesenchymal transition in glioblastoma progression | Oncology Letters | 2016 | 207 |
10 | Molecular mechanisms of chemoresistance in osteosarcoma (Review) | Oncology Letters | 2014 | 194 |
11 | The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC | Oncology Letters | 2016 | 190 |
12 | Histological and molecular aspects of oral squamous cell carcinoma (Review) | Oncology Letters | 2014 | 188 |
13 | Cervical cancer in low and middle‑income countries (Review) | Oncology Letters | 2020 | 185 |
14 | Regulation of let-7 and its target oncogenes (Review) | Oncology Letters | 2012 | 170 |
15 | MicroRNAs and cancer: Key paradigms in molecular therapy (Review) | Oncology Letters | 2017 | 168 |
16 | Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review) | Oncology Letters | 2018 | 160 |
17 | Lauren classification and individualized chemotherapy in gastric cancer | Oncology Letters | 2016 | 157 |
18 | Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma | Oncology Letters | 2017 | 156 |
19 | The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis | Oncology Letters | 2017 | 152 |
20 | The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review) | Oncology Letters | 2018 | 147 |
21 | Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms | Oncology Letters | 2014 | 143 |
22 | Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer | Oncology Letters | 2017 | 139 |
23 | Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review) | Oncology Letters | 2015 | 128 |
24 | Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases (Review) | Oncology Letters | 2018 | 127 |
25 | Progress in the chemotherapeutic treatment of osteosarcoma (Review) | Oncology Letters | 2018 | 126 |
26 | Specific organ metastases and survival in small cell lung cancer | Oncology Letters | 2012 | 125 |
27 | Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway | Oncology Letters | 2016 | 125 |
28 | Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells | Oncology Letters | 2016 | 125 |
29 | Voltage-gated calcium channels: Novel targets for cancer therapy | Oncology Letters | 2017 | 124 |
30 | Differential expression of miRNAs in esophageal cancer tissue | Oncology Letters | 2013 | 121 |
31 | Antitumor mechanisms of bifidobacteria (Review) | Oncology Letters | 2018 | 120 |
32 | A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review) | Oncology Letters | 2013 | 117 |
33 | Molecular and cellular mechanisms of castration resistant prostate cancer (Review) | Oncology Letters | 2018 | 116 |
34 | Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis | Oncology Letters | 2015 | 115 |
35 | Metformin and cancer: An existing drug for cancer prevention and therapy (Review) | Oncology Letters | 2018 | 115 |
36 | Oncology during the COVID‑19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients (Review) | Oncology Letters | 2020 | 115 |
37 | Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients | Oncology Letters | 2015 | 114 |
38 | Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression | Oncology Letters | 2014 | 112 |
39 | Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer | Oncology Letters | 2017 | 109 |
40 | Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer | Oncology Letters | 2012 | 108 |
41 | The role of MALAT1 correlates with HPV in cervical cancer | Oncology Letters | 2014 | 108 |
42 | Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF–κB, uPA activator and MMP9 | Oncology Letters | 2016 | 108 |
43 | Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer | Oncology Letters | 2017 | 108 |
44 | Fatty acid activation in carcinogenesis and cancer development: Essential roles of long‑chain acyl‑CoA synthetases (Review) | Oncology Letters | 2018 | 105 |
45 | BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma | Oncology Letters | 2014 | 104 |
46 | Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer | Oncology Letters | 2015 | 104 |
47 | BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition | Oncology Letters | 2014 | 103 |
48 | Age is a prognostic factor affecting survival in lung cancer patients | Oncology Letters | 2013 | 102 |
49 | Molecular mechanisms of tamoxifen-associated endometrial cancer (Review) | Oncology Letters | 2015 | 102 |
50 | Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells | Oncology Letters | 2013 | 101 |